Comparison of Different Insoles as Conservative Treatment for Medial Knee Osteoarthritis

Sponsor
University Hospital Inselspital, Berne (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04967339
Collaborator
(none)
25
1
2
24
1

Study Details

Study Description

Brief Summary

In patients with early to mid-stage knee osteoarthritis (OA), a conservative treatment is indicated. In medial knee OA (when mainly the medial compartment of the knee is affected by OA), lateral wedge insoles have been promoted as cost effective and simple solution. However, clinical trials report conflicting results, with some reporting no benefit while others reported a small decrease in knee pain. Recent studies reported medial OA patients to have a tendency to a plano-valgus foot deformity, which is associated with a varus lower limb alignment and an internal rotation of the tibia. Some authors thus proposed the correction of plano-valgus deformity with foot deformity correcting insoles instead of lateral wedge insoles. Until today, only one study investigated the effect of foot deformity correcting insoles (e.g. with medial arch support) as alternative to lateral wedge insoles and reported encouraging results. However, they used lateral wedge insoles with custom arch support instead of foot deformity correcting customized insoles along (without lateral wedge). Furthermore, they did not perform any biomechanical analyses. The primary object of this study is to compare the effect of foot deformity correcting insoles for plano-valgus foot deformities and lateral wedge insoles on knee load distribution, knee pain and patient reported outcome measures in early to mid-stage medial knee OA patients after 6 and 12 months.

Condition or Disease Intervention/Treatment Phase
  • Device: Foot deformity correcting insoles
  • Device: Lateral wedge insoles
Phase 4

Detailed Description

Osteoarthritis (OA) of the knee is defined as an inflammatory process leading to loss of protective cartilage which results in pain, disability and loss of function. Around 25% of the population between 55 and 84 years is affected by OA of the knee. It can be graded using various classification, one of the most used being the Kellgren-Lawrence-Score (KL) ranging from 1 (early) to 4 (end stage). The treatment of choice for end-stage three compartmental knee OA (KL 4) is a total knee arthroplasty (TKA), whereby the damaged/degenerated parts of the knee are removed and replaced by a prosthesis. However, in patients with early to mid-stage OA (KL 1-3), which are usually younger patients, a conservative treatment is indicated. The goal of this conservative treatment is to relieve symptoms and at best slow progression of the diseases.

In medial knee OA (when mainly the medial compartment of the knee is affected by OA), one approach is to reduce the medial compartment contact force (MCF) by shifting load from the medial (disease affected) to lateral (disease free) compartment. Thereby lateral wedge insoles have been promoted as cost effective and simple solution. The biomechanical idea of these insoles is a shift in load distribution through a change in lower limb alignment. The lateral wedge of the insoles leads to a change in foot alignment (varus hindfoot) and consequently to a change in knee alignment (valgus knee = "knock-knees") and load distribution. Biomechanical studies confirmed a reduction in external knee adduction moment (EKAM) and knee adduction angular impulse (KAAI), which are surrogate measures to estimate knee joint load distribution (e.g. MCF). However, clinical trials report conflicting results, with some reporting no benefit while others reported a small decrease in knee pain in at least some patients.

In the light of this, the connection between knee OA and foot deformities has been reassessed. One study found patients with medial knee OA to have a more pronated foot type (i.e. tendency to plano-valgus deformity) compared to an age-matched control group without OA. Other investigations found more rigid foot types in patients with medial knee OA and a more internally rotated tibia during gait as well as an inversion of the forefoot. This seems important because the hindfoot axis has a significant influence on the mechanical axis of the lower limb and thereby on the load distribution in the knee. Half a degree valgisation of the hindfoot axis leads to one-degree varisation of the mechanical axis. Furthermore, a plano-valgus foot morphology was found to lead to internal rotation of the tibia which increases shear forces in the medial knee compartment.

In summary, patients with medial knee OA tend to have a plano-valgus foot deformity which is associated with a varus lower limb alignment and an internal rotation of the tibia. Both have been associated to an increased loading of the medial compartment. Consequently, some authors proposed the correction of plano-valgus deformity with customized foot deformity correcting insoles instead of lateral wedge insoles as conservative treatment option for early to mid-stage medial knee OA. Until today, only one study investigated the effect of foot deformity correcting insoles (e.g. insoles with customized medial arch support) as alternative to lateral wedge insoles and reported encouraging results. However, they used lateral wedge insoles with and without medial arch support and did not explicitly only correct the foot deformity. Furthermore, they did not perform any biomechanical analysis, which seems important since some previous studies found significant differences in KAAI and EKAM among patients.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
25 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized control trialRandomized control trial
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Randomized Control Trial in Patients With Medial Knee Osteoarthritis Comparing the Clinical and Biomechanical Effect of Foot Deformity Correcting Insoles and Lateral Wedge Insoles
Anticipated Study Start Date :
Aug 1, 2021
Anticipated Primary Completion Date :
Aug 1, 2023
Anticipated Study Completion Date :
Aug 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Foot deformity correcting insole arm

Patients allocated to the "foot deformity correcting insole" arm will receive insoles to correct their foot deformities (plano-valgus foot deformity).

Device: Foot deformity correcting insoles
Foot deformity correcting insoles (e.g. insoles with medial arch support for plano-valgus deformity)

Active Comparator: Lateral wedge insole arm

Patient allocated to the "Lateral wedge insole" arm will receive conventional lateral wedge insole.

Device: Lateral wedge insoles
Lateral wedge insoles

Outcome Measures

Primary Outcome Measures

  1. Numeric pain scale (NRS) [pre-treatment]

  2. Numeric pain scale (NRS) [3 months]

  3. Numeric pain scale (NRS) [6 months]

  4. Numeric pain scale (NRS) [12 months]

  5. External knee adduction moment (EKAM) [pre-treatment]

  6. External knee adduction moment (EKAM) [3 months]

  7. External knee adduction moment (EKAM) [6 months]

  8. External knee adduction moment (EKAM) [12 months]

  9. Knee adduction angular impulse (KAAI) [pre-treatment]

  10. Knee adduction angular impulse (KAAI) [3 months]

  11. Knee adduction angular impulse (KAAI) [6 months]

  12. Knee adduction angular impulse (KAAI) [12 months]

  13. Western Ontario and McMaster OA Index (WOMAC) [pre-treatment]

  14. Western Ontario and McMaster OA Index (WOMAC) [3 months]

  15. Western Ontario and McMaster OA Index (WOMAC) [6 months]

  16. Western Ontario and McMaster OA Index (WOMAC) [9 months]

  17. Western Ontario and McMaster OA Index (WOMAC) [12 months]

  18. Knee Injury and Osteoarthritis Outcome Score (KOOS) [pre-treatment]

  19. Knee Injury and Osteoarthritis Outcome Score (KOOS) [3 months]

  20. Knee Injury and Osteoarthritis Outcome Score (KOOS) [6 months]

  21. Knee Injury and Osteoarthritis Outcome Score (KOOS) [12 months]

  22. Oxford-12 Knee Score (OKS) [pre-treatment]

  23. Oxford-12 Knee Score (OKS) [3 months]

  24. Oxford-12 Knee Score (OKS) [6 months]

  25. Oxford-12 Knee Score (OKS) [12 months]

  26. Knee Society Score (KSS) [pre-treatment]

  27. Knee Society Score (KSS) [3 months]

  28. Knee Society Score (KSS) [6 months]

  29. Knee Society Score (KSS) [12 months]

  30. EQ-5D [pre-treatment]

  31. EQ-5D [3 months]

  32. EQ-5D [6 months]

  33. EQ-5D [12 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Informed Consent signed by the subject

  • Aged between 40 to 80 years

  • Early to mid-stage (KL 1 - 3) OA of the medial compartment of the knee based on X-ray and MRI images

  • Plano-valgus foot deformity based on clinical assessment

  • Availability of conventional radiographs, long-leg films, and a knee-MRI no older than 1 year at time of inclusion

  • Ability to walk without walking aid for more than 15min

Exclusion Criteria:
  • Contraindications and limitations of the MD as described in the instructions for use.

  • Inability to follow the procedures of the investigation, e.g. due to language problems, psychological disorders, dementia, etc. of the subject,

  • Enrolment of the PI, his/her family members, employees and other dependent persons

  • Relevant OA (Kellgren-Lawrence-Score >2) of the lateral compartment of the knee based on X-ray and MRI images

  • BMI higher than 40 kg/m

  • Fix varus deformities over 20 degrees

  • Neurological or rheumatoid diseases of any kind

  • History of high tibial osteotomy, other realignment surgery of the knee or foot

  • Foot or ankle problems that contraindicated the use of footwear load-modifying interventions

  • Relevant ligamentous instability

Contacts and Locations

Locations

Site City State Country Postal Code
1 Universitätsklinik für Orthopädische Chirurgie und Traumatologie Inselspital Bern Switzerland 3010

Sponsors and Collaborators

  • University Hospital Inselspital, Berne

Investigators

  • Principal Investigator: Frank Klenke, Prof, Universitätsklinik für Orthopädische Chirurgie und Traumatologie Inselspital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier:
NCT04967339
Other Study ID Numbers:
  • 2021-InsoleStudy
First Posted:
Jul 19, 2021
Last Update Posted:
Jul 19, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by University Hospital Inselspital, Berne
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 19, 2021